Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chakra Biotech Of Malaysia Invests To Attract MNC Drug Testing

This article was originally published in PharmAsia News

Executive Summary

Malaysia's Chakra Biotech plans to invest $8 million in a facility with a neurobehavioral laboratory it expects to begin operating in two months with a staff of 80. The lab is to focus on testing drugs for treating disorders of the central nervous system and is in talks to test drugs for three multinational pharmaceutical companies. CEO Anthony Bishop said Chakra planned to take advantage of a $30 billion market for drug-testing services. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070757

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel